Investment in Colorectal Cancer Screening Programs Targeting Pre-Medicare Population Could Reduce Treatment Costs in the Medicare Population
American College of Gastroenterology (ACG)Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, could reduce the costs of colorectal cancer in the Medicare program, according to a study. According to the findings, the up-front investment in screening individuals aged 50 to 64 was recouped only after they transition to Medicare at age 65.